• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

普萘洛尔、可乐定、乌拉地尔和曲唑酮输注治疗特发性震颤:一项双盲交叉试验。

Propranolol, clonidine, urapidil and trazodone infusion in essential tremor: a double-blind crossover trial.

作者信息

Caccia M R, Osio M, Galimberti V, Cataldi G, Mangoni A

机构信息

Neurological Clinic, L. Sacco Hospital, Milan, Italy.

出版信息

Acta Neurol Scand. 1989 May;79(5):379-83. doi: 10.1111/j.1600-0404.1989.tb03804.x.

DOI:10.1111/j.1600-0404.1989.tb03804.x
PMID:2741669
Abstract

Accelerometric tremorgrams were recorded from 25 subjects affected by essential tremor and analysed by a Berg-Fourier frequency analyser before and during venous infusion of the following drugs: propranolol (beta-blocker), clonidine (alpha-presynaptic adrenergic agonist), urapidil (alpha-postsynaptic blocker), trazodone (adrenolytic agent) and placebo. The washout interval between infusions was 3 days. Recordings and data analyses were performed in a double-blind crossover trial. Tremor was classified as: at rest; postural (arms hyperextended); and intention (finger-nose test). Analysis of the results showed that propranolol and clonidine reduced significantly (P = 0.01 and P = 0.009, respectively) the power spectrum of postural tremor, but left at rest and intention tremors unchanged. No significant effects on the tremor power spectrum were observed after placebo, urapidil or trazodone administration. None of the drugs had any effect on tremor frequency.

摘要

对25名特发性震颤患者记录加速计震颤图,并在静脉输注以下药物之前和期间通过伯格 - 傅里叶频率分析仪进行分析:普萘洛尔(β受体阻滞剂)、可乐定(α突触前肾上腺素能激动剂)、乌拉地尔(α突触后阻滞剂)、曲唑酮(抗肾上腺素能药)和安慰剂。两次输注之间的洗脱期为3天。记录和数据分析在双盲交叉试验中进行。震颤分为:静止性;姿势性(手臂过度伸展);意向性(指鼻试验)。结果分析表明,普萘洛尔和可乐定显著降低(分别为P = 0.01和P = 0.009)姿势性震颤的功率谱,但静止性和意向性震颤未改变。给予安慰剂、乌拉地尔或曲唑酮后,未观察到对震颤功率谱有显著影响。没有一种药物对震颤频率有任何影响。

相似文献

1
Propranolol, clonidine, urapidil and trazodone infusion in essential tremor: a double-blind crossover trial.普萘洛尔、可乐定、乌拉地尔和曲唑酮输注治疗特发性震颤:一项双盲交叉试验。
Acta Neurol Scand. 1989 May;79(5):379-83. doi: 10.1111/j.1600-0404.1989.tb03804.x.
2
[Clonidine versus propranolol in the treatment of essential tremor. A double-blind trial with a one-year follow-up].可乐定与普萘洛尔治疗特发性震颤的双盲试验及一年随访
Neurologia. 2003 Jun;18(5):248-54.
3
A randomized placebo-controlled comparative trial of gabapentin and propranolol in essential tremor.加巴喷丁与普萘洛尔治疗特发性震颤的随机安慰剂对照比较试验。
Arch Neurol. 1999 Apr;56(4):475-80. doi: 10.1001/archneur.56.4.475.
4
[Therapeutic effects of trazodone in the treatment of tremor. Multicentric double-blind study].
Riv Neurol. 1986 Nov-Dec;56(6):358-64.
5
Effect of a single oral dose of propranolol on essential tremor: a double-blind controlled study.单次口服普萘洛尔对特发性震颤的影响:一项双盲对照研究。
Ann Neurol. 1983 Feb;13(2):165-71. doi: 10.1002/ana.410130210.
6
Effect of propranolol in head tremor: quantitative study following single-dose and sustained drug administration.普萘洛尔对头震颤的影响:单次给药和持续给药后的定量研究
Clin Neuropharmacol. 1992 Dec;15(6):470-6. doi: 10.1097/00002826-199212000-00004.
7
Adjuvant therapy of parkinsonian tremor.帕金森震颤的辅助治疗。
Arch Neurol. 1987 Sep;44(9):921-3. doi: 10.1001/archneur.1987.00520210023013.
8
Beta 1 versus nonselective blockade in therapy of essential tremor.β1受体阻滞剂与非选择性阻滞剂在特发性震颤治疗中的比较
Adv Neurol. 1983;37:247-51.
9
Clonidine in the treatment of essential tremor.可乐定治疗特发性震颤
Mov Disord. 1986;1(4):235-7. doi: 10.1002/mds.870010403.
10
Selective adrenergic beta-2-receptor blocking drug, ICI-118.551, is effective in essential tremor.选择性肾上腺素能β2受体阻断药物ICI-118.551对特发性震颤有效。
Acta Neurol Scand. 1986 Jul;74(1):34-7. doi: 10.1111/j.1600-0404.1986.tb04622.x.

引用本文的文献

1
Current and Future Neuropharmacological Options for the Treatment of Essential Tremor.治疗原发性震颤的当前和未来神经药理学选择。
Curr Neuropharmacol. 2020;18(6):518-537. doi: 10.2174/1570159X18666200124145743.
2
Pharmacological management of essential tremor.特发性震颤的药物治疗管理。
Drugs. 2010 Dec 3;70(17):2215-28. doi: 10.2165/11538180-000000000-00000.
3
Treatment of fragile X-associated tremor ataxia syndrome (FXTAS) and related neurological problems.脆性X相关震颤共济失调综合征(FXTAS)及相关神经问题的治疗。
Clin Interv Aging. 2008;3(2):251-62. doi: 10.2147/cia.s1794.
4
Benefits and risks of pharmacological treatments for essential tremor.原发性震颤药物治疗的益处与风险。
Drug Saf. 2003;26(7):461-81. doi: 10.2165/00002018-200326070-00003.